Nota 98
Farmaci in nota: aflibercept, bevacizumab (L. 648/96), brolucizumab, ranibizumab
Riferimenti: https://www.aifa.gov.it/nota-98
Farmaci in nota: aflibercept, bevacizumab (L. 648/96), brolucizumab, ranibizumab
Riferimenti: https://www.aifa.gov.it/nota-98